Transform your market access in Asia-Pacific
The Asia-Pacific region is critical to the future growth plans of pharmaceutical manufacturers and PRMA Consulting are leading ground-breaking market access projects in the region.
Fill in your details to watch this webinar
In this on-demand webinar “Transform your market access in Asia-Pacific” regional market access experts offer recommendations for:
- Assessing market access and commercialization risks, opportunities, and evidence needs for products in Asia-Pacific markets
- Improving early planning and cross-functional alignment on local implementation of development programs
- Developing forward-looking integrated evidence generation plans that cover different Asia‑Pacific payer needs
- Leveraging digital tools to transform value and access outcomes in the Asia-Pacific region.
We also celebrate the opening of our new office in Singapore, an important step towards realizing improved market access for manufacturers with an interest in the region.
Presenters: Jan McKendrick, Senior Director and Steve Crowley, MSc, MBA. Independent Senior Advisor.
Jan has more than 25 years’ experience in the pharmaceutical industry, including 4 years as a clinical trial statistician and 11 years in health outcomes at Eli Lilly in the UK. Jan played a key role in developing the strategy for engaging with NICE in its early days, and has extensive experience in developing HTA submissions.
At PRMA Consulting, Jan leads and provides strategic input into projects to develop the evidence base to support the value of products, including translating that information into supporting HTA submissions. She is responsible for setting the vision for the PRMA Healthcheck® digital application, which has been used to determine evidence generation strategies to support optimal market access outcomes, predominantly in Europe but also in the US and Asia-Pacific regions.
Steve Crowley has over 30 years’ experience in HEOR and in pharmaceutical and biotechnology market access. He has extensive knowledge of the Asia-Pacific region, including reimbursement and pricing, policy, and product commercialisation. PRMA Consulting has had the pleasure of working with Steve on several market access projects for medicines in Japan.
Duration: 40 minutes
Ideal viewing: Global Market Access, Global HEOR – particularly those who are involved in the Asia-Pacific region.
“Very informative. The points covered are making me re-think the scope of work I’m considering.”
HEOR Director, leading pharmaceutical company